RGNX
NASDAQ · Biotechnology
Regenxbio Inc
$7.80
-0.10 (-1.27%)
Open$8.20
Previous Close$7.90
Day High$8.58
Day Low$7.78
52W High$16.19
52W Low$5.46
Volume—
Avg Volume1.88M
Market Cap403.24M
P/E Ratio—
EPS$-5.59
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+136.9% upside
Current
$7.80
$7.80
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 193.98M | 169.00M | 81.92M |
| Net Income | -220,655,839 | -173,018,169 | 13.19M |
| Profit Margin | -113.8% | -108.1% | 16.1% |
| EBITDA | -165,692,913 | -137,139,107 | 28.49M |
| Free Cash Flow | — | — | 20.59M |
| Rev Growth | +14.8% | +14.8% | +8.8% |
| Debt/Equity | 1.82 | 1.82 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |